论文信息 - 591. Adintrevimab (ADI) Population Pharmacokinetics (PPK) in Phase 1 and Phase 2/3 COVID-19 Prevention and Treatment Study Participants - 字舞流文

591. Adintrevimab (ADI) Population Pharmacokinetics (PPK) in Phase 1 and Phase 2/3 COVID-19 Prevention and Treatment Study Participants

P. Ambrose | C. Rubino | Myra W. Popejoy | X. Pu | PeterJ. Schmidt | Anthony P. Cammarata | Jean Gong